Invasive ductal carcinoma – Recurrent (USA)

78 year old lady. Biggest history of lumpectomy. And asymptomatic. These are the inside to the views showing the scar, the oil cyst. And. And the symmetry close to the scar. That could only be clearly detected on the criminal calendar view. Let's move. To the turmoil and reconfirm a mass round mass. Indistinct pass very close to the scar from both fields. If we focus in this press. We can't confirm this suspicious, but small mass very close to. They. Scar. And this is the correlation with ultrasound showing this formulator. Mass and the condition with MRI showing this. Tiny must enhancement. The biopsy was performed and this was a recurrence and invasive ductal cancer measuring 4 millimeters. In this case. It's almost synthesis was even better than MRI to show. This lesion.

1/1/2022 11/2/2021 23 5.0 43 3/3 21 9.0 69 Follow Up 1 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS 12_FollowUp_1, PID3691 Healthineers * 1/1/2022 F PID3691 RMLO Series Navigator INSIGHT_2D Add Study PID3691 10/1/2021 (Study date) Prior 02 MG, 5/1/2019 n.a ., 3 years ... Mamografia Bilateral MLO RCC Viewing Favorite Layouts MR DYN US MR.Dyna ... MR.Empty ReportFlow BASIC Printing Tools Findings MR 5:48 PM Clinical information 78-year-old female Lumpectomy in the left breast Asymptomatic SIEMENS . LMLO LCC 10/1/2021 (Study date): Prior 01 Slice 28 / 56; Slice 17 / 49 thickness: 1.00 mm Slice thickness: Slice 20 / 47 Slice thickness: 100 mm C.US | C .... Slice 14/ 47 C.CC Current Subtraction 1 CLINICA UNIVERSITARIA DE NAVARRA 10/25/2021, 10:02:30 AM (Study date) 12:52:15 PM 1 CLINICA UNIVERSITARIA DE 11 IMA 80 10/25/21 10:12:15AM ADM Mama FR Frec 1 L 0.40 cm SP F4.9 p2 SL 1.5 mm Zoom 1.70 BASI 1.5 mm Pathology Recurrent invasive ductal carcinoma (IDC) 4 mm Conclusion DBT showed the recurrent lesion better than MRI. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations.